nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Intestinal obstruction—Topotecan—cervical cancer	0.0125	0.0535	CcSEcCtD
Paliperidone—ADRA1B—renal system—cervical cancer	0.0109	0.0508	CbGeAlD
Paliperidone—Pulmonary embolism—Topotecan—cervical cancer	0.0085	0.0365	CcSEcCtD
Paliperidone—Ear pain—Topotecan—cervical cancer	0.00723	0.031	CcSEcCtD
Paliperidone—HTR1A—renal system—cervical cancer	0.00665	0.031	CbGeAlD
Paliperidone—ADRA1A—epithelium—cervical cancer	0.00661	0.0308	CbGeAlD
Paliperidone—HTR1B—female reproductive system—cervical cancer	0.0066	0.0307	CbGeAlD
Paliperidone—HTR1D—female reproductive system—cervical cancer	0.00639	0.0297	CbGeAlD
Paliperidone—HTR2C—female reproductive system—cervical cancer	0.00633	0.0295	CbGeAlD
Paliperidone—Lethargy—Topotecan—cervical cancer	0.0063	0.027	CcSEcCtD
Paliperidone—ADRA2C—uterine cervix—cervical cancer	0.00624	0.0291	CbGeAlD
Paliperidone—ADRA1A—renal system—cervical cancer	0.00613	0.0285	CbGeAlD
Paliperidone—ADRA2C—decidua—cervical cancer	0.00595	0.0277	CbGeAlD
Paliperidone—Cardiac arrest—Topotecan—cervical cancer	0.00587	0.0252	CcSEcCtD
Paliperidone—ADRA2C—renal system—cervical cancer	0.00584	0.0272	CbGeAlD
Paliperidone—ADRA2C—endometrium—cervical cancer	0.00565	0.0263	CbGeAlD
Paliperidone—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00556	0.0238	CcSEcCtD
Paliperidone—ADRA2C—mammalian vulva—cervical cancer	0.00546	0.0254	CbGeAlD
Paliperidone—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00544	0.0234	CcSEcCtD
Paliperidone—CYP3A5—uterine cervix—cervical cancer	0.00523	0.0243	CbGeAlD
Paliperidone—ADRA2C—uterus—cervical cancer	0.0052	0.0242	CbGeAlD
Paliperidone—HRH1—epithelium—cervical cancer	0.00512	0.0238	CbGeAlD
Paliperidone—HRH1—uterine cervix—cervical cancer	0.00507	0.0236	CbGeAlD
Paliperidone—Neutropenia—Topotecan—cervical cancer	0.00499	0.0214	CcSEcCtD
Paliperidone—ADRA2A—uterine cervix—cervical cancer	0.00498	0.0232	CbGeAlD
Paliperidone—CYP3A5—renal system—cervical cancer	0.00489	0.0228	CbGeAlD
Paliperidone—Weight increased—Topotecan—cervical cancer	0.00486	0.0208	CcSEcCtD
Paliperidone—HRH1—decidua—cervical cancer	0.00483	0.0225	CbGeAlD
Paliperidone—Pneumonia—Topotecan—cervical cancer	0.00478	0.0205	CcSEcCtD
Paliperidone—Infestation NOS—Topotecan—cervical cancer	0.00476	0.0204	CcSEcCtD
Paliperidone—Infestation—Topotecan—cervical cancer	0.00476	0.0204	CcSEcCtD
Paliperidone—ADRA2A—decidua—cervical cancer	0.00475	0.0221	CbGeAlD
Paliperidone—HRH1—endometrium—cervical cancer	0.00459	0.0214	CbGeAlD
Paliperidone—ADRA2A—endometrium—cervical cancer	0.00451	0.021	CbGeAlD
Paliperidone—Hepatobiliary disease—Topotecan—cervical cancer	0.0045	0.0193	CcSEcCtD
Paliperidone—Epistaxis—Topotecan—cervical cancer	0.00449	0.0192	CcSEcCtD
Paliperidone—HRH1—mammalian vulva—cervical cancer	0.00444	0.0207	CbGeAlD
Paliperidone—ADRA2A—mammalian vulva—cervical cancer	0.00436	0.0203	CbGeAlD
Paliperidone—Rhinitis—Topotecan—cervical cancer	0.00428	0.0184	CcSEcCtD
Paliperidone—HTR2A—epithelium—cervical cancer	0.00427	0.0199	CbGeAlD
Paliperidone—ADRA2C—female gonad—cervical cancer	0.00426	0.0198	CbGeAlD
Paliperidone—Hypoaesthesia—Topotecan—cervical cancer	0.00425	0.0182	CcSEcCtD
Paliperidone—ADRA2C—vagina—cervical cancer	0.00423	0.0197	CbGeAlD
Paliperidone—ADRA2A—uterus—cervical cancer	0.00415	0.0193	CbGeAlD
Paliperidone—HTR2A—renal system—cervical cancer	0.00396	0.0184	CbGeAlD
Paliperidone—Angiopathy—Topotecan—cervical cancer	0.00387	0.0166	CcSEcCtD
Paliperidone—Immune system disorder—Topotecan—cervical cancer	0.00386	0.0165	CcSEcCtD
Paliperidone—Mediastinal disorder—Topotecan—cervical cancer	0.00385	0.0165	CcSEcCtD
Paliperidone—Chills—Topotecan—cervical cancer	0.00383	0.0164	CcSEcCtD
Paliperidone—HRH1—female reproductive system—cervical cancer	0.0038	0.0177	CbGeAlD
Paliperidone—Alopecia—Topotecan—cervical cancer	0.00377	0.0162	CcSEcCtD
Paliperidone—ADRA2A—female reproductive system—cervical cancer	0.00373	0.0174	CbGeAlD
Paliperidone—Malnutrition—Topotecan—cervical cancer	0.00372	0.0159	CcSEcCtD
Paliperidone—CYP3A4—renal system—cervical cancer	0.00367	0.0171	CbGeAlD
Paliperidone—CYP2D6—renal system—cervical cancer	0.00361	0.0168	CbGeAlD
Paliperidone—Back pain—Topotecan—cervical cancer	0.0036	0.0154	CcSEcCtD
Paliperidone—Muscle spasms—Topotecan—cervical cancer	0.00357	0.0153	CcSEcCtD
Paliperidone—CYP3A5—female gonad—cervical cancer	0.00356	0.0166	CbGeAlD
Paliperidone—CYP3A5—vagina—cervical cancer	0.00354	0.0165	CbGeAlD
Paliperidone—HRH1—female gonad—cervical cancer	0.00346	0.0161	CbGeAlD
Paliperidone—Ill-defined disorder—Topotecan—cervical cancer	0.00345	0.0148	CcSEcCtD
Paliperidone—HRH1—vagina—cervical cancer	0.00344	0.016	CbGeAlD
Paliperidone—Anaemia—Topotecan—cervical cancer	0.00344	0.0147	CcSEcCtD
Paliperidone—Angioedema—Topotecan—cervical cancer	0.0034	0.0146	CcSEcCtD
Paliperidone—ADRA2A—female gonad—cervical cancer	0.0034	0.0158	CbGeAlD
Paliperidone—ADRA2A—vagina—cervical cancer	0.00338	0.0157	CbGeAlD
Paliperidone—Malaise—Topotecan—cervical cancer	0.00335	0.0144	CcSEcCtD
Paliperidone—Leukopenia—Topotecan—cervical cancer	0.00333	0.0143	CcSEcCtD
Paliperidone—Cough—Topotecan—cervical cancer	0.00324	0.0139	CcSEcCtD
Paliperidone—HTR2A—female reproductive system—cervical cancer	0.00317	0.0148	CbGeAlD
Paliperidone—Chest pain—Topotecan—cervical cancer	0.00316	0.0136	CcSEcCtD
Paliperidone—Myalgia—Topotecan—cervical cancer	0.00316	0.0136	CcSEcCtD
Paliperidone—Arthralgia—Topotecan—cervical cancer	0.00316	0.0136	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00314	0.0135	CcSEcCtD
Paliperidone—Discomfort—Topotecan—cervical cancer	0.00313	0.0134	CcSEcCtD
Paliperidone—Anaphylactic shock—Topotecan—cervical cancer	0.00303	0.013	CcSEcCtD
Paliperidone—Infection—Topotecan—cervical cancer	0.00301	0.0129	CcSEcCtD
Paliperidone—Nervous system disorder—Topotecan—cervical cancer	0.00298	0.0128	CcSEcCtD
Paliperidone—Thrombocytopenia—Topotecan—cervical cancer	0.00297	0.0127	CcSEcCtD
Paliperidone—Skin disorder—Topotecan—cervical cancer	0.00295	0.0126	CcSEcCtD
Paliperidone—CYP3A4—female reproductive system—cervical cancer	0.00294	0.0137	CbGeAlD
Paliperidone—Anorexia—Topotecan—cervical cancer	0.00289	0.0124	CcSEcCtD
Paliperidone—CYP2D6—female reproductive system—cervical cancer	0.00289	0.0135	CbGeAlD
Paliperidone—HTR2A—vagina—cervical cancer	0.00287	0.0134	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00276	0.0119	CcSEcCtD
Paliperidone—ADRA2C—lymph node—cervical cancer	0.00274	0.0127	CbGeAlD
Paliperidone—Paraesthesia—Topotecan—cervical cancer	0.00272	0.0117	CcSEcCtD
Paliperidone—Dyspnoea—Topotecan—cervical cancer	0.0027	0.0116	CcSEcCtD
Paliperidone—Dyspepsia—Topotecan—cervical cancer	0.00267	0.0115	CcSEcCtD
Paliperidone—Decreased appetite—Topotecan—cervical cancer	0.00264	0.0113	CcSEcCtD
Paliperidone—CYP2D6—female gonad—cervical cancer	0.00263	0.0122	CbGeAlD
Paliperidone—Gastrointestinal disorder—Topotecan—cervical cancer	0.00262	0.0112	CcSEcCtD
Paliperidone—Fatigue—Topotecan—cervical cancer	0.00262	0.0112	CcSEcCtD
Paliperidone—Pain—Topotecan—cervical cancer	0.00259	0.0111	CcSEcCtD
Paliperidone—Constipation—Topotecan—cervical cancer	0.00259	0.0111	CcSEcCtD
Paliperidone—Feeling abnormal—Topotecan—cervical cancer	0.0025	0.0107	CcSEcCtD
Paliperidone—Gastrointestinal pain—Topotecan—cervical cancer	0.00248	0.0106	CcSEcCtD
Paliperidone—Urticaria—Topotecan—cervical cancer	0.00241	0.0103	CcSEcCtD
Paliperidone—Body temperature increased—Topotecan—cervical cancer	0.0024	0.0103	CcSEcCtD
Paliperidone—Abdominal pain—Topotecan—cervical cancer	0.0024	0.0103	CcSEcCtD
Paliperidone—Hypersensitivity—Topotecan—cervical cancer	0.00224	0.00959	CcSEcCtD
Paliperidone—HRH1—lymph node—cervical cancer	0.00222	0.0103	CbGeAlD
Paliperidone—ADRA2A—lymph node—cervical cancer	0.00218	0.0102	CbGeAlD
Paliperidone—Asthenia—Topotecan—cervical cancer	0.00218	0.00934	CcSEcCtD
Paliperidone—Pruritus—Topotecan—cervical cancer	0.00215	0.00921	CcSEcCtD
Paliperidone—Diarrhoea—Topotecan—cervical cancer	0.00208	0.0089	CcSEcCtD
Paliperidone—Dizziness—Topotecan—cervical cancer	0.00201	0.00861	CcSEcCtD
Paliperidone—Vomiting—Topotecan—cervical cancer	0.00193	0.00827	CcSEcCtD
Paliperidone—Rash—Topotecan—cervical cancer	0.00191	0.00821	CcSEcCtD
Paliperidone—Dermatitis—Topotecan—cervical cancer	0.00191	0.0082	CcSEcCtD
Paliperidone—Headache—Topotecan—cervical cancer	0.0019	0.00815	CcSEcCtD
Paliperidone—Nausea—Topotecan—cervical cancer	0.0018	0.00773	CcSEcCtD
Paliperidone—DRD3—Signaling Pathways—WNT2—cervical cancer	0.000481	0.000871	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.000475	0.000861	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000472	0.000855	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000471	0.000854	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000464	0.000841	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000464	0.00084	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000463	0.000839	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000463	0.000838	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CA9—cervical cancer	0.000458	0.000829	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000455	0.000824	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000454	0.000822	CbGpPWpGaD
Paliperidone—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000438	0.000793	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.000434	0.000786	CbGpPWpGaD
Paliperidone—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.000432	0.000782	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000428	0.000775	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000426	0.000771	CbGpPWpGaD
Paliperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000423	0.000765	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000422	0.000765	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000422	0.000765	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000422	0.000764	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000419	0.000759	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.000417	0.000755	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000417	0.000755	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.00041	0.000743	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000405	0.000734	CbGpPWpGaD
Paliperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000405	0.000733	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000399	0.000723	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000381	0.00069	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CA9—cervical cancer	0.000372	0.000674	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000369	0.000669	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000368	0.000666	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000368	0.000666	CbGpPWpGaD
Paliperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000367	0.000665	CbGpPWpGaD
Paliperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000366	0.000663	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000366	0.000663	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000364	0.00066	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000362	0.000656	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000361	0.000654	CbGpPWpGaD
Paliperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000359	0.000651	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000356	0.000645	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000354	0.000642	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.00035	0.000635	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CA9—cervical cancer	0.000341	0.000617	CbGpPWpGaD
Paliperidone—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00033	0.000599	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000329	0.000597	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000329	0.000596	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000323	0.000585	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000318	0.000576	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000318	0.000575	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000317	0.000574	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000316	0.000572	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000311	0.000564	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000307	0.000557	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000302	0.000548	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000299	0.000541	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000293	0.00053	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000289	0.000524	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000288	0.000521	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000279	0.000505	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000497	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000496	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000269	0.000487	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000259	0.000469	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000256	0.000463	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.00025	0.000452	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000245	0.000444	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CA9—cervical cancer	0.000242	0.000439	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HES1—cervical cancer	0.00024	0.000435	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HES1—cervical cancer	0.000236	0.000428	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000231	0.000418	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000223	0.000404	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000222	0.000402	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.000391	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000215	0.000389	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HES1—cervical cancer	0.000213	0.000385	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000212	0.000384	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TERT—cervical cancer	0.00021	0.000381	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HES1—cervical cancer	0.00021	0.00038	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TERT—cervical cancer	0.000207	0.000375	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000197	0.000357	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000196	0.000354	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000193	0.000349	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000193	0.000349	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000192	0.000348	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.00019	0.000344	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000189	0.000343	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000189	0.000341	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—TP53—cervical cancer	0.000186	0.000337	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TERT—cervical cancer	0.000186	0.000337	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000186	0.000337	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000185	0.000335	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TERT—cervical cancer	0.000184	0.000333	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000183	0.000331	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000182	0.000329	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000181	0.000328	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000178	0.000323	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000177	0.00032	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000175	0.000317	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000174	0.000315	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TP53—cervical cancer	0.000174	0.000315	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000171	0.00031	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000169	0.000305	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000166	0.0003	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000165	0.000298	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—EGFR—cervical cancer	0.000161	0.000292	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HES1—cervical cancer	0.00016	0.000291	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.00016	0.000291	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TERT—cervical cancer	0.00016	0.00029	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000159	0.000289	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000159	0.000288	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CA9—cervical cancer	0.000158	0.000287	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000158	0.000287	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000158	0.000286	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HES1—cervical cancer	0.000158	0.000285	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000155	0.000281	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000155	0.00028	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000152	0.000276	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000152	0.000276	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000151	0.000273	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000147	0.000266	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000146	0.000265	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000144	0.00026	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000143	0.000259	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000143	0.000259	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000142	0.000258	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—cervical cancer	0.000141	0.000256	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000141	0.000255	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TERT—cervical cancer	0.000141	0.000255	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.00014	0.000253	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000139	0.000251	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000138	0.000251	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—MTHFR—cervical cancer	0.000138	0.000251	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TERT—cervical cancer	0.000138	0.00025	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000138	0.00025	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000137	0.000249	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MTOR—cervical cancer	0.000136	0.000246	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000135	0.000245	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000134	0.000242	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000133	0.000242	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000131	0.000238	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000129	0.000234	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.000127	0.000231	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000127	0.000231	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.00023	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.000229	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000126	0.000228	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CASP3—cervical cancer	0.000125	0.000226	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000124	0.000225	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000123	0.000223	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000123	0.000223	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CASP3—cervical cancer	0.000123	0.000222	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000122	0.000221	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000121	0.000219	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	0.00012	0.000218	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MTOR—cervical cancer	0.00012	0.000218	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000216	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000215	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000215	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000119	0.000215	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000118	0.000214	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000117	0.000212	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000211	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000115	0.000209	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000111	0.0002	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000109	0.000198	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000108	0.000196	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000108	0.000195	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.000107	0.000194	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000107	0.000194	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000107	0.000193	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000192	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000192	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CTNNB1—cervical cancer	0.000105	0.00019	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—STAT3—cervical cancer	0.000105	0.00019	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000188	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000103	0.000187	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—STAT3—cervical cancer	0.000103	0.000187	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000103	0.000186	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000181	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CASP3—cervical cancer	9.85e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MTOR—cervical cancer	9.84e-05	0.000178	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—cervical cancer	9.83e-05	0.000178	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EGFR—cervical cancer	9.73e-05	0.000176	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.66e-05	0.000175	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EGFR—cervical cancer	9.53e-05	0.000173	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CASP3—cervical cancer	9.51e-05	0.000172	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	9.49e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CASP3—cervical cancer	9.46e-05	0.000171	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EGFR—cervical cancer	9.38e-05	0.00017	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—STAT3—cervical cancer	9.29e-05	0.000168	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CASP3—cervical cancer	9.2e-05	0.000167	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—STAT3—cervical cancer	9.17e-05	0.000166	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	9.16e-05	0.000166	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	9.12e-05	0.000165	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MTOR—cervical cancer	9.08e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CASP3—cervical cancer	9.05e-05	0.000164	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MTOR—cervical cancer	8.93e-05	0.000162	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MTOR—cervical cancer	8.91e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	8.87e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MTOR—cervical cancer	8.74e-05	0.000158	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	8.73e-05	0.000158	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EGFR—cervical cancer	8.44e-05	0.000153	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CASP3—cervical cancer	8.35e-05	0.000151	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EGFR—cervical cancer	8.33e-05	0.000151	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—STAT3—cervical cancer	8.28e-05	0.00015	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—cervical cancer	8.21e-05	0.000149	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—cervical cancer	8.2e-05	0.000148	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—cervical cancer	8.17e-05	0.000148	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MTOR—cervical cancer	8.12e-05	0.000147	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CTNNB1—cervical cancer	8.05e-05	0.000146	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—cervical cancer	8.04e-05	0.000146	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—cervical cancer	8e-05	0.000145	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—cervical cancer	7.99e-05	0.000145	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—cervical cancer	7.95e-05	0.000144	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	7.92e-05	0.000143	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CTNNB1—cervical cancer	7.9e-05	0.000143	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—cervical cancer	7.88e-05	0.000143	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	7.75e-05	0.00014	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—cervical cancer	7.73e-05	0.00014	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—cervical cancer	7.61e-05	0.000138	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—cervical cancer	7.52e-05	0.000136	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—cervical cancer	7.47e-05	0.000135	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—cervical cancer	7.26e-05	0.000132	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—cervical cancer	7.22e-05	0.000131	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.2e-05	0.00013	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—cervical cancer	7.09e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—cervical cancer	7.03e-05	0.000127	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—cervical cancer	7.01e-05	0.000127	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—cervical cancer	7e-05	0.000127	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—cervical cancer	6.91e-05	0.000125	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—cervical cancer	6.9e-05	0.000125	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—cervical cancer	6.89e-05	0.000125	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—cervical cancer	6.76e-05	0.000122	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—cervical cancer	6.43e-05	0.000116	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—cervical cancer	6.38e-05	0.000115	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—cervical cancer	6.32e-05	0.000114	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.28e-05	0.000114	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—cervical cancer	6.27e-05	0.000114	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—cervical cancer	6.26e-05	0.000113	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—cervical cancer	6.14e-05	0.000111	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—cervical cancer	6.1e-05	0.00011	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—cervical cancer	6.06e-05	0.00011	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—cervical cancer	5.9e-05	0.000107	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—cervical cancer	5.81e-05	0.000105	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.71e-05	0.000103	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—cervical cancer	5.35e-05	9.7e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—cervical cancer	5.27e-05	9.54e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—cervical cancer	5.26e-05	9.52e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—cervical cancer	5.16e-05	9.34e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.79e-05	8.68e-05	CbGpPWpGaD
